Sabina | glpwinner
Founder of GLP Winner, providing transparency around GLP-1 providers. Advocate for GLP-1 accessibility, serial tech entrepreneur, and caregiver of 2 dogs and an aging parent.
| Platform |  | Pricing | Only free issues | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 21 | Founded | a year ago | Last Issue | 21 days ago |
| Active | |||||
Read this Newsletter
lawliepop.substack.comLatest Issues
FDA Enforcement - 503B GLP-1 Compounding
The FDA published a warning letter to ProRx, a 503B compounding pharmacy specifically mentioning that 503Bs should not be compounding GLP-1s. The letter was just made public, but was initially sent to ProRx on April 7, 2026. They stopped ma...
FDA to Remove GLP-1s for 503B Pharmacies?
Apr 30, 2026 - The FDA announced a proposal to remove semaglutide, tirzepatide, and liraglutide from the 503B bulks list. This would prevent 503B pharmacies from compounding GLP-1s. It is important to remember it’s not removed yet, just in...
Visiting 4 Compounding Pharmacies who make GLP-1s
I spent a full day visiting 4 different pharmacies in Houston, TX. This included a small, two medium, and a large pharmacy.
Pharmacies visited:
AGErite (503A)
Empower (503A and 503B, but I only visited the 503A)
VialsRx (503A)
Opt...
BPI labs stops compounding GLP-1s
May mean all 503Bs stop GLP-1 production
Breaking News: BPI is out of the compounded GLP-1 game.
This may mean shortages for people on compounded GLP-1s and likely also means that all 503Bs will stop.
Should patients stock up? I don’t...
Eli Lilly vs Mochi Hearing
Last August I went to the first hearing for the case and it seemed like it was a slam dunk for Mochi. The judge wasn’t buying anything Lilly said and wanted to see more concrete facts and evidence.
Today when I went to the second hearing i...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Sabina.
| Subscribers | Engagement | 71 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Founder of GLP Winner which helps compare GLP-1 providers with transparent reviews, sourcing, and pricing. GLP-1 accessibility with news on litigation, policy and information on the Telehealth landscape.
Frequently Asked Questions
How can I access the email archive for Sabina?
You can find recent issues that have been published by Sabina on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Sabina have?
To see how many people subscribe to Sabina, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Sabina?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Sabina as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Sabina?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Sabina using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Sabina?
Scroll up to where it says Related Newsletters to see other publications like Sabina. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Sabina?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.